Immunocore Hldgs (NASDAQ: IMCR)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Immunocore Hldgs (NASDAQ: IMCR) through any online brokerage.
The latest price target for Immunocore Hldgs (NASDAQ: IMCR) was reported by HC Wainwright & Co. on Tuesday, February 8, 2022. The analyst firm set a price target for 80.00 expecting IMCR to rise to within 12 months (a possible 163.42% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Immunocore Hldgs (NASDAQ: IMCR) is $30.37 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Immunocore Hldgs.
Immunocore Hldgs’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Immunocore Hldgs.
Immunocore Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.